In summary, we constructed a lymph node metastasis-related predictive signature based on TEKT2 and RPGR expression to predict the prognosis, immune infiltration, and efficiency of individualized therapeutic agents. Here, RPGR is linked to metastatic malignant neoplasm in the lymph nodes.